[1]杜彦挺 综述 潘亚文 审校.Moyamoya病的诊断和治疗的研究进展[J].中国临床神经外科杂志,2015,(12):761-763.[doi:10.13798/j.issn.1009-153X.2015.12.021]
点击复制

Moyamoya病的诊断和治疗的研究进展()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2015年12期
页码:
761-763
栏目:
论著
出版日期:
2015-12-30

文章信息/Info

文章编号:
1009-153X(2015)12-0761-03
作者:
杜彦挺 综述 潘亚文 审校
730030 兰州,兰州大学第二医院神经外科
通讯作者:潘亚文,E-mail:panyawen666@sohu.com
关键词:
Moyamoya病发病机制诊断治疗
分类号:
R 743
DOI:
10.13798/j.issn.1009-153X.2015.12.021
文献标志码:
B

参考文献/References:

[1] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health La- bour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 245-266.
[2] Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome [J]. N Engl J Med, 2009, 360(12): 1226-1237.
[3] Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological surve [J]. Stroke, 2008, 39(1): 42-47.
[4] Miyawaki S, Imai H, Takayanagi S, et al. Identification of a genetic variant common to moyamoya disease and intracra- nial major artery stenosis/occlusion [J]. Stroke, 2012, 43 (12): 3371-3374.
[5] Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 267-277.
[6] Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting [J]. J Neurol Neurosurg Psy- chiatry, 2006, 77(9): 1025-1029.
[7] Liu W, Morito D, Takashima S, et al. Identification of RNF 213 as a susceptibility gene for moyamoya disease and its possible role in vascular development [J]. PLoS One, 2011, 6(7): e22542.
[8] Wu Z, Jiang H, Zhang L, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population [J]. PLoS One, 2012, 7(10): e48179.
[9] 戴冬伟,赵文元,黄清海,等. 血清microRNA在烟雾病发 病机制中的潜在作用[J]. 中华神经外科疾病研究杂志, 2013,:150-154.
[10] Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives [J]. Lancet Neurol, 2008, 7(11): 1056-1066.
[11] Vimalesvaran S, Nachiappan N, Sithamparanathan Y. Mo- yamoya syndrome in a Malaysian child with Down syn- drome [J]. J Paediatr Child Health, 2013, 49(10): 865-868.
[12] Jagannath AD, Rastogi U, Spooner AE, et al. Aortic dissec- tion and moyamoya disease in Turner syndrome [J]. Am J Med Genet A, 2010, 152A(8), 2085-2089.
[13] Tanghetti B, Capra R, Giunta F, et al. Moyamoya syndrome in only one of two identical twins: case report [J]. J Neuro- surg, 1983, 59(6): 1092-1094.
[14] Manion B, Sung WS. Radiation-induced moyamoya disease after childhood astrocytoma [J]. J Clin Neurosci, 2011, 18 (10): 1403-1405.
[15] Tanigawara T, Yamada H, Sakai N, et al. Studies on cytome- galovirus and Epstein-Barr virus infection in moyamoya disease [J]. Clin Neurol Neurosurg 1997, 99(Suppl): S225- 228.
[16] Okada Y, Kawamata T, Kawashima A, et al. The efficacy of superficial temporal artery-middle cerebral artery anasto- mosis in patients with moyamoya disease complaining of severe headache [J]. J Neurosurg, 2012, 116(3): 672-679.
[17] Mogensen MA, Karzmark P, Zeifert PD, et al. Neuroradio- logic correlates of cognitive impairment in adult Moyamoya disease [J]. Am J Neuroradiol, 2012, 33(4): 721-725.
[18] Smith ER, Scott RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with pro- posed evidence-based practice guidelines: a review [J]. J Neurosurg Pediatr, 2012, 9(4): 353-360.
[19] Fujimura M, Niizuma K, Endo H, et al. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syn- drome after revascularization surgery for moyamoya disease [J]. Neurol Res, 2015, 37(2): 131-138.
[20] 李雅强,李 俊,张 戈,等. 连续40例出血型烟雾病的 DSA影像学分析[J]. 中国临床神经外科杂志,2009,14 (10):592-594.
[21] Liu W, Zhu S, Wang X, et al. Evaluation of angiographic changes of the anterior choroidal and posterior communica- ting arteries for predicting cerebrovascular lesions in adult moyamoya disease [J]. J Clin Neurosci, 2011, 18(3): 374- 378.
[22] Khan N, Achrol AS, Guzman R, et al. Sex differences in cli- nical presentation and treatment outcomes in Moyamoya di- sease [J]. Neurosurgery, 2012, 71(3): 587-593.
[23] Kim SJ, Heo KG, Shin HY, et al. Association of thyroid au- toantibodies with moyamoya-type cerebrovascular disease: a prospective study [J]. Stroke, 2010, 41(1): 173-176.
[24] Guzman R, Steinberg GK. Direct bypass techniques for the treatment of pediatric moyamoya disease [J]. Neurosurg Clin N Am, 2010, 21(3): 565-573.
[25] 丁大成,陈谦学,秦 军,等. 高压氧辅助STA-MCA搭桥 术治疗烟雾病的临床疗效[J]. 中国临床神经外科杂志, 2014,19:719-722.
[26] 陈劲草,周 平,欧一博,等. 联合血管重建术治疗烟雾病 疗效分析[J]. 中国临床神经外科杂志,2011,16:581-583.

相似文献/References:

[1]陈 娟 张华楸 综述 雷 霆 审校.库欣病发病机制的研究进展[J].中国临床神经外科杂志,2015,(10):594.[doi:10.13798/j.issn.1009-153X.2015.10.006]
[2]王米君 综述 舒 凯 审校.脑膜瘤瘤周水肿的研究现状[J].中国临床神经外科杂志,2015,(05):315.[doi:10.13798/j.issn.1009-153X.2015.05.022]
[3]管得宁,张 扬,徐 运.帕金森病的发病机制及治疗研究进展[J].中国临床神经外科杂志,2016,(11):732.[doi:10.13798/j.issn.1009-153X.2016.11.031]
[4]陆丽娟,李玉凤,赵喜庆 综述,等.氯离子通道与胶质瘤的关系研究进展[J].中国临床神经外科杂志,2016,(12):803.[doi:10.13798/j.issn.1009-153X.2016.12.029]
[5]吴 超 于 涛 王振宇 段丽萍.脊髓损伤后神经源性肠功能障碍的发生机制[J].中国临床神经外科杂志,2017,(04):282.[doi:10.13798/j.issn.1009-153X.2017.04.030]
[6]吕艳霞 李安荣 杨朋磊 综述 胡钧涛 审校.炎症反应在颅内动脉瘤发生中作用的研究进展[J].中国临床神经外科杂志,2017,(05):363.[doi:10.13798/j.issn.1009-153X.2017.05.030]
[7]马 涛.颅脑损伤后凝血功能障碍的机制及干预措施[J].中国临床神经外科杂志,2017,(08):601.[doi:10.13798/j.issn.1009-153X.2017.08.030]
[8]田 杨 综述,史怀璋 审校.非编码RNA参与颅内动脉瘤病理机制的研究进展[J].中国临床神经外科杂志,2018,(10):701.[doi:10.13798/j.issn.1009-153X.2018.10.021]
[9]曾子桓 张 灏 陈伟强 魏梁锋 王守森.颅脑损伤后继发性脑损伤发病机制的研究进展[J].中国临床神经外科杂志,2019,(12):777.[doi:10.13798/j.issn.1009-153X.2019.12.022]
[10]汤其华 综述 张剑宁 审校.颅骨纤维结构不良研究新进展[J].中国临床神经外科杂志,2020,(09):639.[doi:10.13798/j.issn.1009-153X.2020.09.023]

更新日期/Last Update: 2016-12-30